Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Roivant Sciences Ltd. - Common Shares
(NQ:
ROIV
)
12.91
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Roivant Sciences Ltd. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Earnings Scheduled For November 15, 2021
November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021
November 08, 2021
Upgrades For Nektar Therapeutics (NASDAQ:
Via
Benzinga
Roivant Discovery Announces 2021 Open Science Fellows
October 29, 2021
From
Roivant Discovery
Via
Business Wire
60 Biggest Movers From Yesterday
October 27, 2021
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the...
Via
Benzinga
Why Roivant Sciences Stock Is Soaring Today
October 26, 2021
Three analysts initiated positive coverage on the biotech stock.
Via
The Motley Fool
40 Stocks Moving In Tuesday's Mid-Day Session
October 26, 2021
Gainers Wallbox N.V. (NYSE: WBX) shares climbed 54.5% to $17.16. Uber and Wallbox N.V. disclosed a strategic partnership to simplify the transition to EVs for Bay Area ride...
Via
Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
October 21, 2021
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) rose 34.9% to $13.44 in pre-market trading after announcement of a proposed merger with Trump Media & Technology Group...
Via
Benzinga
Topics
Government
36 Biggest Movers From Yesterday
October 06, 2021
Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares climbed 36.4% to settle at $10.35 on Tuesday amid an increase in the price of Bitcoin and Ethereum. Zeta Global Holdings Corp. (...
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; PepsiCo Beats Q3 Views
October 05, 2021
Following the market opening Tuesday, the Dow traded up 0.78% to 34,267.10 while the NASDAQ rose 1.03% to 14,402.90. The S&P also rose, gaining 0.89% to 4,338.68. The U.S. has...
Via
Benzinga
Topics
Stocks
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...
Via
Benzinga
44 Biggest Movers From Yesterday
October 05, 2021
Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced its phase 2 study of XEN1101 for the treatment of...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.